Sneddon syndrome
Vascular skin · Dermatology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A non-inflammatory arteriopathy combining widespread livedo racemosa with recurrent ischaemic strokes, often associated with antiphospholipid antibodies.
Red flags
- Acute stroke / TIA
- Cognitive decline
- Positive antiphospholipid antibodies
- Recurrent thrombotic events
Assessment
Differential diagnosis
- Antiphospholipid syndrome
- Vasculitis
- Cholesterol embolisation
- Thrombotic microangiopathy
- CADASIL
Investigations
- MRI brain (ischaemic lesions)
- Antiphospholipid antibody screen
- Skin biopsy of livedo
- Thrombophilia screen
- Echocardiography / vascular assessment
Management
- Assess for acute stroke and manage per stroke pathway
- Recognise the livedo-plus-stroke pattern
- Screen for antiphospholipid antibodies
- Neurology and dermatology / rheumatology referral
- Antithrombotic therapy (specialist decision)
- Manage vascular risk factors
Drugs & doses
Antiplatelet or anticoagulant therapy (specialist)
Vascular risk factor modification
Manage acute stroke per protocol
Disposition
Admit for stroke workup; neurology + dermatology/rheumatology.
Complications & pitfalls
- Recurrent stroke
- Vascular dementia
- Systemic thrombosis
Exam pearls
- Consider it in a young patient with stroke and widespread livedo racemosa.
- Antiphospholipid antibodies are frequently positive.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.